Skip to content
ACCP JOURNALS cover art

All Episodes

ACCP JOURNALS — 190 episodes · page 1 of 2

#
Title
1

What Gets Measured Isn't Always What Matters Most - Ep 192

2

Opportunities to Intensify Lipid-Lowering Therapy – Ep 191

3

Hormone Therapy in Menopause: Expert Insights - Ep 190

4

Research and Scholarly Methods Using Artificial Intelligence: Choosing the Right Approach and Tools - Ep 189

5

Leaders in Clinical Pharmacy: Peter H. Vlasses, PharmD, DSc (Hon), FCCP - Episode 78

6

Ambient AI use in Ambulatory Pharmacy Clinical Practice - Ep 187

7

Comparative Analysis of Nafcillin and Oxacillin: Implications for MSSA Treatment - Ep 186

8

Pharmacotherapy and AI: Beyond the Fear, Towards Collaboration - Ep 185

9

Getting Published in JACCP: Tips for Success - Ep 184

10

Predicting Fall Risks in Older Adults with Depression: A Machine Learning Approach - Ep 183

11

Reimagining Renal Assessment: Pros and Cons - Ep 182

12

Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181

13

High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180

14

Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179

15

A Medical Writing Rotation: Flipping the Odds on Resident Scholarship - Ep 178

16

Thinking Like Tree Farmers Not Muffin Makers:  Why We Need a Competency-based Framework at all Levels of Professional Education - Ep 177

17

An Aging HIV+ Population:  The Urgent Need (and Opportunities) for HIV-trained Pharmacists - Ep 176

18

Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175

19

The Missing Piece: Recasting Pharmacists in Popular Media - Ep 174

20

Kidney Damage Biomarkers - Ep 173

21

Leveraging Real World Data to Identify Pediatric Drug Safety Knowledge Gaps - Ep 172

22

Turning Curiosity into Research Ideas, Questions, and Aims - Ep 171

23

Career Pathways in Drug Development - Ep 170

24

Effect of P2Y12 inhibitors on MACE after CABG surgery - Ep 169

25

Integrating critical care pharmacists into intensive care unit teams - Ep 168

26

Managing ADHD in a breastfeeding mother - Ep 167

27

Urgency and Optimism: Key Takeaways from the National Academy of Medicine Workshop on Innovations in Pharmacy Training and Practice - Ep 166

28

PK/PD evaluation of sulbactam-durlobactam in a critically ill patient - Ep 165

29

Addressing knowledge gaps in opioid use among pediatric and maternal patient populations - Ep 164

30

Finding correlation between PhORCAS letters of recommendation and clinical aptitude among PGY1 residency candidates - Ep 163

31

Achieving Bidirectional Health Information Exchange with Community Pharmacies - Ep 162

32

Evaluating the Economic Impact of Pharmacist Interventions: Improving Patient Care and the Bottom Line - Ep 161

33

Updates in Chronic Kidney Disease Management - Ep 160

34

Impact of AI on clinical pharmacy practice, research and scholarship - Ep 159

35

Antibiotic Safety in Pregnancy - Ep 158

36

Removing Oral Phenylephrine from the Market - Ep 157

37

Prevalence of prescription medication use that can exacerbate heart failure - Ep 156

38

Genetic Testing & Formularies: Optimizing Medication Safety & Effectiveness - Ep 155

39

Disease modifying therapies for ATTR-CM - Ep 154

40

Innovations in Diabetes Management: Insights from JACCP’s Themed Issue - Ep 153

41

PCSK9-directed Therapies - Ep 152

42

Aztreonam-avibactam - Ep 151

43

Leaders in Clinical Pharmacy: Stuart T. Haines, Pharm.D., FCCP, FAPhA, FASHP, BCACP, BCPS - Ep 150

44

Efficacy & safety of SGLT2Is following ACS & CABG in patients with T2DM - Ep 149

45

Choosing the best vancomycin PK model for your patient - Ep 148

46

Should the FDA be requiring a Risk Evaluation and Mitigation Strategy for mifepristone? - Ep 147

47

Advancing interprofessional patient care through interprofessional education - Ep 146

48

The Powers and Pitfalls of Underpowered Studies - Ep 145

49

State-based laws and regulations supporting pharmacist payment for clinical services - Ep 144

50

Empowering Pharmacists with Data to Improve Medication Safety - Ep 143

51

Integration of the Key Potentially Inappropriate Drugs in Pediatrics List to Improve Patient Safety - Ep 142

52

Consensus recommendations for the use of long-acting antiretrovirals - Ep 141

53

Building a robust pharmacy research program - Ep 140

54

Applying pharmacogenomic test interpretation to patient care - Ep 139

55

Treating persons with HIV who are heavily treatment-experienced or have MDR HIV-1 - Ep 138

56

Impact of internal medicine pharmacists on antimicrobial stewardship - Ep 137

57

Dosing warfarin in a postpartum woman who’s breastfeeding - Ep 136

58

Planning, Funding & Implementing a Stewardship Program - Ep 135

59

Pharmacotherapy updates in pulmonary drug-resistant tuberculosis - Ep 134

60

Advice for Residency Programs RE: Non-US Candidates - Ep 133

61

A Core Outcome Set for Psychiatric Pharmacists - Ep 132

62

What's the relationship between clozapine and inflammation? - Ep 131

63

Pharmacokinetics of Levocarnitine in Septic Shock - Ep 130

64

Reducing Readmission Rates - Ep 129

65

Leaders in Clinical Pharmacy: Leigh Ann Ross, Pharm.D., FCCP, FAPhA, FASHP, FNAP - Ep 128

66

Warfarin patient self management - Ep 127

67

Impact of COVID-19 on pharmacy practice faculty scholarly outcomes - Ep 126

68

Standards of Practice for Clinical Pharmacists - Ep 125

69

Triazole Antifungal Therapeutic Drug Monitoring - Ep 124

70

Theophylline in the 21st century - Ep 123

71

Critical care pharmacist-led interventions on pain, agitation, and delirium - Ep 122

72

Prolonged Infusion Beta-Lactams - Ep 121

73

Addressing threats to pharmacist well-being through work redesign - Ep 120

74

Medical cannabis - Ep 119

75

Management of Adverse Effects of Antidepressant Medications in Children and Adolescents - Ep 118

76

Rationale for the use of mineralocorticoid receptor antagonists in heart failure - Ep 117

77

Opinions in JACCP: Assuring All Pharmacy Graduates are "Team-Ready" Clinicians - Ep 116

78

Opinions in JACCP: Community-based pharmacy practice is reinventing itself - Ep 115

79

Opinions in JACCP: Clinical Pharmacy Practice in Community Pharmacies - Ep 114

80

Opinions in JACCP: Rethinking the medication review process - Ep 113

81

Opinions in JACCP: Roles of the clinical pharmacist during COVID-19 - Ep 112

82

Opinions in JACCP: Hero Clinical Pharmacists and the COVID-19 Pandemic - Ep 111

83

Opinions in JACCP: Pharmacist Harm Reduction Roles in the Opioid Crisis - Ep 110

84

Opinions in JACCP: Specialty Certification - Ep 109

85

Opinions in JACCP: Elevating Scholarship of Teaching and Learning - Ep 108

86

Opinions in JACCP: Gender Disparities - Ep 107

87

Opinions in JACCP: Cybersecurity Management - Ep 106

88

Medical Misinformation - Ep 105

89

Management of noncytotoxic extravasation injuries - Ep 104

90

Leaders in Clinical Pharmacy: Jimmi Hatton Kolpek, Pharm.D., FCCP, FCCM, FNAP - Ep 103

91

Leaders in Clinical Pharmacy: Marie Chisholm-Burns, Pharm.D., Ph.D., MPH, MBA, FCCP, FASHP, FAST

92

Quality measures to help define the importance and value of CMM as a key component of population health management - Ep 102

93

PGY1 Pharmacy Residency Equivalency - Ep 101

94

Pre-lung transplant statin use on the development of primary graft dysfunction - Ep 100

95

Risk of bleeding with factor Xa inhibitors vs UFH in patients with AKI - Ep 99

96

Incorporating health equity into postgraduate pharmacy training - Ep 98

97

Clinical Practice Guidelines - Ep 97

98

What is a pharmacy fellowship? What kinds of fellowship are available? - Ep. 96

99

Rational polytherapy in patients with drug-resistant epilepsy - Ep 95

100

Vancomycin vs. Fidaxomicin for CDI - Ep 94